Company Overview of CBA Pharma, Inc.
CBA Pharma, Inc. a pharmaceutical company manufactures, markets, licenses, and distributes drugs for medical oncology community. Its CBT-1, reverses multi-drug resistance in cancer cells and enables the chemotherapy to treat cancer. CBA Pharma, Inc. was formerly known as CBA Pharmaceuticals, Inc. The company was incorporated in 1999 and is based in Lexington, Kentucky.
670 Perimeter Drive
Lexington, KY 40517
Founded in 1999
Key Executives for CBA Pharma, Inc.
CBA Pharma, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact CBA Pharma, Inc., please visit www.cbapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.